Cost-effectiveness analysis in oncology (Q58057613)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653486%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Cost-effectiveness analysis in oncology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653486%20AND%20SRC:MED&resulttype=core&format=json

cost-effectiveness analysis

12 November 2019

main subject

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653486%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

C C Earle

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653486%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

W K Evans

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653486%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 May 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653486%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653486%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653486%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653486%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

475-482

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653486%20AND%20SRC:MED&resulttype=core&format=json

Quality assurance procedures in radiotherapy. Economic criteria to support decision making

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

A model for calculating the costs of in vivo dosimetry and portal imaging in radiotherapy departments

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Comparison of plastic and Orfit® masks for patient head fixation during radiotherapy: Precision and costs

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

European School of Oncology Advisory report to the Commission of the European Communities for the "Europe Against Cancer Programme" cost-effectiveness in cancer care.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Utilities and quality-adjusted life years

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

The design of future cost-benefit studies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Indirect costs in economic studies: confronting the confusion

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Economic analyses in health care: an introduction to the methodology with an emphasis on radiation therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

The distinction between cost and charges

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Discounting and health benefits

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Discounting of health benefits in the pharmacoeconomic analysis of drug therapies: an issue for debate?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Discounting and health benefits: another perspective

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Generalisation from phase III clinical trials: survival, quality of life, and health economics.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Cost Effectiveness of Low-Dose Zidovudine Therapy for Asymptomatic Patients with Human Immunodeficiency Virus (HIV) Infection

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Cost-effectiveness league tables: More harm than good?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Cost-utility in practice: a policy maker's guide to the state of the art.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Statistical analysis in pharmacoeconomic studies. A review of current issues and standards.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292128615

7 January 2021

Identifiers

DOI

10.1023/A:1008292128615

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653486%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference